References
- 1. P. Bonfanti et al., Citologia e Istologia. Idelson - Gnocchi, 2010.
- 2. M. Feldmannn, F. M. Brennan, and R. N. Maini, Role of cytokines in rheumatoid arthritis, Annu. Rev. Immunol., vol. 14, pp. 397–440, 1996.
- 3. A. S. Fauci et al., Harrison-Principi di Medicina Interna. McGraw-Hill, 2009.
- 4. S. Adami et al., Reumatologia per Studenti e Medici di Medicina Generale. Idelson - Gnocchi, 2008.
- 5. M. Jit, B. Henderson, M. Stevens, and M. Seymour, TNF-alpha neutralization in cytokine-driven disease: a mathematical model to account for therapeutic success in rheumatoid arthritis but therapeutic failure in systemic inflammatory response syndrome, Rheumatology, vol. 44, pp. 323–331, 2005.
- 6. J. Y. Lee et al., Molecular basis for the neutralization of tumor necrosis factor α by Certolizumab Pegol in the treatment of inflammatory autoimmune diseases, Int. J. Mol. Sci., vol. 18, p. 228, 2017.
- 7. V. I. Smirnov, A Course of Higher Mathematics. Volume IV. Oxford: Pergamon Press, 1964.
- 8. E. T. Whittaker and G. N. Watson, A Course of Modern Analysis. Cambridge: Cambridge University Press, 1958.
- 9. M. Abramowitz and I. A. Stegun, Handbook of Mathematical Functions with Formulas, Graphs and Mathematical Tables. New-York: Dover, 1970.
- 10. A. Kavanaugh et al., Chimeric anti-tumor necrosis factor-monoclonal antibody treatment of patients with rheumatoid arthritis receiving methotrexate therapy, J. Rheumatol., vol. 27, pp. 841–850, 2000.
- 11. L. Moreland et al., Etanercept therapy in rheumatoid arthritis. A randomized, controlled trial, Ann. Intern. Med., vol. 130, pp. 478–486, 1999.